Roivant Sciences (STU:87S) Receivables Turnover : 7.26 (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Roivant Sciences Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Roivant Sciences's Revenue for the three months ended in Dec. 2024 was €8.6 Mil. Roivant Sciences's average Accounts Receivable for the three months ended in Dec. 2024 was €1.2 Mil. Hence, Roivant Sciences's Receivables Turnover for the three months ended in Dec. 2024 was 7.26.

Roivant Sciences Receivables Turnover Historical Data

The historical data trend for Roivant Sciences's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roivant Sciences Receivables Turnover Chart

Roivant Sciences Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Receivables Turnover

14.26

3.59

2.96

Roivant Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Receivables Turnover	Get a 7-Day Free Trial														0.33	2.14	0.83	0.11	7.26

Competitive Comparison of Roivant Sciences's Receivables Turnover

For the Biotechnology subindustry, Roivant Sciences's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roivant Sciences's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roivant Sciences's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Roivant Sciences's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Roivant Sciences Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Roivant Sciences's Receivables Turnover for the fiscal year that ended in Mar. 2024 is calculated as

	Receivables Turnover (A: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Mar. 2024 )	/ (	(Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )
=	114.811	/ (	(28.374	+	49.261)	/	2 )
=	114.811	/	38.8175
=	2.96

Roivant Sciences's Receivables Turnover for the quarter that ended in Dec. 2024 is calculated as

	Receivables Turnover (Q: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2024 )	/ (	(Accounts Receivable (Q: Sep. 2024 )	+	Accounts Receivable (Q: Dec. 2024 ))	/	count )
=	8.612	/ (	(1.726	+	0.647)	/	2 )
=	8.612	/	1.1865
=	7.26

Roivant Sciences (STU:87S) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Roivant Sciences Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Roivant Sciences's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Roivant Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roivant Sciences Ltd (STU:87S) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

ROIV:USA

Address

50 Broadway, 7th Floor, London, GBR, SW1H 0BD

Website

https://www.roivant.com

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Roivant Sciences Headlines

No Headlines